Molnupiravir; molecular and functional descriptors of mitochondrial safety
Sign Up to like & getrecommendations! Published in 2022 at "Toxicology and Applied Pharmacology"
DOI: 10.1016/j.taap.2022.116003
Abstract: Molnupiravir is an orally active nucleoside analog antiviral drug that recently was approved by the U.S. FDA for emergency treatment of adult patients infected with the SARS-CoV-2 (COVID-19) virus and at risk for severe progression.… read more here.
Keywords: molnupiravir molecular; molnupiravir; descriptors mitochondrial; functional descriptors ... See more keywords